"Designing Growth Strategies is in our DNA"
Ankylosing spondylitis (AS) is a form of arthritis that primarily affects the spine causing long term inflammation of spine, shoulder, and hip joints. As spondylitis progress between the joints of ribs and spine, it eventually restricts the movement of the chest making it difficult to breathe properly. Ankylosing spondylitis in its advanced stage causes vertebrae fractures. Pain and swelling in a finger or toe, tenderness at the base of the pelvis, chest pain and tiredness are some of the symptoms associated with ankylosing spondylitis which generally appears in the age group 17 to 45 years or during late adolescence. Currently, there is no specific cure for ankylosing spondylitis, but some of the treatments and medications are available to reduce the symptoms and helps in the management of the pain.
Nonsteroidal anti-inflammatory drugs (NSAIDs), biologics including anti-TNF and anti-IL-17 drugs are some of the medications used to reduce the pain and swelling. Frequent back exercise and fitness activities can also aid in managing the symptoms associated with ankylosing spondylitis. Growing demand for effective therapies for the treatment of ankylosing spondylitis and emerging drugs under clinical trials are likely to boost the ankylosing spondylitis treatment market during the forecast period.
To gain extensive insights into the market, Request for Customization
Increasing prevalence of ankylosing spondylitis, introduction of biologics in the market, rising awareness about new diagnostics methods, and emerging treatment options for ankylosing spondylitis are likely to drive the growth of ankylosing spondylitis treatment market during the forecast period. Additionally, growing initiatives by government in improving healthcare infrastructure and strong pipeline drugs are likely to fuel the growth of ankylosing spondylitis treatment market during the forecast period.
However, due to the lack of skilled surgeons in low-middle income countries, unavailability of effective drugs for the treatment, and high cost of the treatment are likely to hinder the ankylosing spondylitis treatment market during the forecast period.
Some of the major companies that are present in the global ankylosing spondylitis treatment market are AbbVie Inc., Janssen Pharmaceuticals Inc., Pfizer Inc., Sandoz International GmbH, Amgen Inc., Protalix BioTherapeutics, Inc., Reliance Life Sciences Pvt. Ltd., Momenta Pharmaceuticals Inc., Celgene Corporation, Regeneron Pharmaceuticals, Merck & Co. Inc., among others.
- Nonsteroidal anti-inflammatory Drugs (NSAIDs)
- Disease-modifying anti-rheumatic Drugs (DMARDs)
- Immunotherapy Drugs
· Physical Therapy
By End User
· Ambulatory Surgery Centres
· North America (U.S. and Canada)
· Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
· Latin America (Brazil, Mexico, and Rest of Latin America)
· Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)
Among treatment, immunotherapy drugs segment is anticipated to hold the largest market share during the forecast period as they are considered as more safe and effective than nonsteroidal anti-inflammatory drugs. For instance, in 2018, Eli Lilly and Company have announced positive results of Taltz (ixekizumab) which was in phase-3 for the treatment of ankylosing spondylitis (AS).
Overview of Pipeline Drugs
Advancements in Treatment of Ankylosing Spondylitis
Epidemiology Analysis of Ankylosing Spondylitis
The Regulatory Scenario of Key Countries/Regions
Recent Key Industry Developments – Mergers, Acquisitions, And Partnerships.
Geographically, the global ankylosing spondylitis treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe is anticipated to hold a considerable share of the global ankylosing spondylitis treatment market owing to growing investments in research and development activities, increasing adoption of ankylosing spondylitis treatment options, and increase in the prevalence of ankylosing spondylitis. In 2018, according to the state of musculoskeletal health reports, it was estimated that 200,000 people in the UK were affected by ankylosing spondylitis. Ankylosing spondylitis treatment market is likely to expand in Asia Pacific region at a significant rate owing to growing patient population, rise in the investments by government-funded organizations in improving the healthcare infrastructure in order to enhance the quality care of patients with ankylosing spondylitis.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry